Drug interactions involving oral anticoagulants.
D000818:Animals; D000925:Anticoagulants / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D001463:Barbiturates / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D002792:Cholestyramine Resin / Q000494:pharmacology; D002994:Clofibrate / Q000494:pharmacology; D004221:Disulfiram / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology; D004285:Dogs; D004347:Drug Interactions; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects; D007700:Kinetics; D008107:Liver Diseases / Q000378:metabolism; D010653:Phenylbutazone / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D011517:Prothrombin Time; D051381:Rats; D011955:Receptors, Drug; D012459:Salicylates / Q000494:pharmacology; D012709:Serum Albumin / Q000378:metabolism; D013997:Time Factors; D014812:Vitamin K / Q000494:pharmacology; D014813:Vitamin K Deficiency / Q000378:metabolism
D000925:Anticoagulants; D001463:Barbiturates; D001779:Blood Coagulation Factors; D004232:Diuretics; D011955:Receptors, Drug; D012459:Salicylates; D012709:Serum Albumin; D002792:Cholestyramine Resin; D014812:Vitamin K; D006493:Heparin; D010653:Phenylbutazone; D002994:Clofibrate; D004221:Disulfiram